Pathways that Regulate Antigrowth Effects of Interferons
Pathways that Regulate Antigrowth Effects of Interferons
批准号:
7409544
负责人:
ANDREW Charles LARNER
金额:
$24.38万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-10 至 2010-04-30
关键词:
Antiviral ResponseApoptosisApoptoticB-LymphocytesBone MarrowCell DeathCell LineCell ProliferationCessation of lifeComplexCultured CellsDominant-Negative MutationERG geneEventGene ActivationGenesGoalsGrowthIfniIn VitroInduction of ApoptosisInterferon ActivationInterferonsInterleukin-7Knockout MiceLeadLymphocytic choriomeningitis virusMalignant NeoplasmsMediatingMitochondriaModalityModelingMolecularMusNatural ImmunityPathway interactionsPatternPhosphotransferasesPlayPrincipal InvestigatorPropertyProtein Tyrosine KinaseProteinsRegulationResistanceRoleSpleenStimulusTranscription factor genesTyrosineTyrosine PhosphorylationVirusWild Type Mousecell growthcell typecytokinedesignin vivoin vivo Modelpreventprogramsresearch studyresponsetranscription factor
中文摘要
1型干扰素是天然免疫和抗病毒反应的关键调节剂。施展他们的行动
它们通常也会抑制细胞生长。干扰素抑制细胞增殖的机制各不相同
许多情况还没有得到很好的理解。在某些细胞中,1型干扰素(干扰素/13)可诱导细胞凋亡;
其他细胞系IFNod_在不诱导细胞凋亡的情况下抑制细胞生长,在某些情况下
细胞因子实际上通过其他刺激来阻止细胞凋亡。在体内和在细胞培养中,干扰素_T3刺激细胞凋亡
未成熟的B细胞。基因敲除小鼠依赖BLL-7 B细胞的初步结果
STAT1、STAT1、STAT5a/b或TYK2表达表明干扰素激活了受调控早期反应基因
转录因子STAT1和STAT2对IFNcdl3的促凋亡作用不是必需的。然而,
酪氨酸激酶TYK2的表达是IFNodl3刺激ProB细胞死亡所必需的,以及
这些细胞因子激活STAT3。这些体外结果在体内也可以看到,TYK2基因缺失的小鼠
抵抗巨细胞病毒刺激的B细胞从骨髓和脾的损失。我们假设干扰素_
介导的细胞凋亡需要TYK2的激酶活性,导致酪氨酸磷酸化。
STAT3及其转录因子对导致ProB细胞程序性死亡的基因调控
细胞。
具体目标是:
1.确定干扰素诱导IL-7依赖的骨细胞凋亡所需的TYK2结构域
骨髓来源的B细胞。
2.确定磷酸化STAT3在IFNI刺激的B细胞PCD中的作用
3.确定依赖IL-7的原代B细胞中需要TYK2表达的蛋白质
激活STAT3,引起IFNI刺激的细胞凋亡。
英文摘要
Type 1 interferons are critical regulators of innate immunity and antiviral responses. To exert their actions
they often also inhibit cell growth. The mechanisms by which interferons inhibit cell proliferation vary and in
many circumstances are not well understood. In some cells type 1 interferons (IFN_/13) induce apoptosis; in
other cell lines IFNod_ inhibit cell growth without induction of apoptosis, and in certain circumstances these
cytokines actually prevent apoptosis by other stimuli. In vivo and in cell culture, IFN_t3 stimulates apoptosis
of immature B cells. Preliminary results using bll-7-dependent B cells from knock out mice that do not
express Statl, Statl, Stat5a/b, or Tyk2 indicate that interferon activation of early response genes regulated
by the Statl and Stat2 transcription factors is not necessary for the apoptotic actions of IFNcdl3. However,
expression of the tyrosine kinase Tyk2 is required for IFNodl3 stimulated death of pro B cells as well as
activation of Stat3 by these cytokines. These in vitro results are also seen in vivo where Tyk2-null mice are
resistant to LCMV stimulated loss of B cells from bone marrow and spleen. We hypothesize that IFN_
mediated apoptosis requires the kinase activity of Tyk2, resulting in tyrosine phosphorylation of
Stat3 and regulation of genes by this transcription factor that lead to programmed cell death of pro B
cells.
The Specific Aims are:
1. Determine the domains in Tyk2 required for IFN_ stimulated apoptosis of IL-7-dependent bone
marrow-derived B cells.
2. Determine the role of phosphorylated Stat3 in IFNI_ stimulated PCD of B cells
3. Identify proteins in primary IL-7 dependent B cells that require the expression of Tyk2 to
activate Stat3 and cause IFNI_ stimulated apoptosis.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Type I interferons activate apoptosis in a Jurkat cell variant by caspase-dependent and independent mechanisms.
I 型干扰素通过半胱天冬酶依赖性和独立机制激活 Jurkat 细胞变体的细胞凋亡。
DOI:
10.1016/j.cellsig.2005.10.008
发表时间:
2006
期刊:
Cellular signalling
影响因子:
4.8
作者:
[Gamero,AnaM, Potla,Ramesh, Sakamoto,Shuji, Baker,DarrenP, Abraham,Robert, Larner,AndrewC]
通讯作者:
Larner,AndrewC
The Role of the tyrosine kinase Tyk2 in regulation of obesity
-
批准号:8705101
-
项目类别:
-
资助金额:$31.26万
-
财政年份:2014
-
负责人:ANDREW Charles LARNER
-
依托单位:
The Role of the tyrosine kinase Tyk2 in regulation of obesity
-
批准号:9061676
-
项目类别:
-
资助金额:$29.88万
-
财政年份:2014
-
负责人:ANDREW Charles LARNER
-
依托单位:
The Jak/Stat Pathway and Mitochondrial Function
-
批准号:8461525
-
项目类别:
-
资助金额:$27.41万
-
财政年份:2012
-
负责人:ANDREW Charles LARNER
-
依托单位:
The Jak/Stat Pathway and Mitochondrial Function
-
批准号:8297262
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2012
-
负责人:ANDREW Charles LARNER
-
依托单位:
The Jak/Stat Pathway and Mitochondrial Function
-
批准号:8651502
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2012
-
负责人:ANDREW Charles LARNER
-
依托单位:
The Jak/Stat Pathway and Mitochondrial Function
-
批准号:8835118
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2012
-
负责人:ANDREW Charles LARNER
-
依托单位:
Novel Signaling Mechanisms of Stat Transcription Factors
-
批准号:8080407
-
项目类别:
-
资助金额:$21.92万
-
财政年份:2010
-
负责人:ANDREW Charles LARNER
-
依托单位:
Novel Signaling Mechanisms of Stat Transcription Factors
-
批准号:7875414
-
项目类别:
-
资助金额:$18.4万
-
财政年份:2010
-
负责人:ANDREW Charles LARNER
-
依托单位:
The Role of Stat1 in Mitochondria
-
批准号:7213560
-
项目类别:
-
资助金额:$18.63万
-
财政年份:2007
-
负责人:ANDREW Charles LARNER
-
依托单位:
The Role of Stat1 in Mitochondria
-
批准号:7670764
-
项目类别:
-
资助金额:$18.27万
-
财政年份:2007
-
负责人:ANDREW Charles LARNER
-
依托单位:
Signaling in Cells Chronically Exposed to Interferons
-
批准号:7466011
-
项目类别:
-
资助金额:$20.47万
-
财政年份:2005
-
负责人:ANDREW Charles LARNER
-
依托单位:
Signaling in Cells Chronically Exposed to Interferons
-
批准号:7595149
-
项目类别:
-
资助金额:$27.12万
-
财政年份:2005
-
负责人:ANDREW Charles LARNER
-
依托单位:
Signaling in Cells Chronically Exposed to Interferons
-
批准号:7231618
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2005
-
负责人:ANDREW Charles LARNER
-
依托单位:
Signaling in Cells Chronically Exposed to Interferons
-
批准号:6988352
-
项目类别:
-
资助金额:$25.87万
-
财政年份:2005
-
负责人:ANDREW Charles LARNER
-
依托单位:
Signaling in Cells Chronically Exposed to Interferons
-
批准号:7094237
-
项目类别:
-
资助金额:$29.72万
-
财政年份:2005
-
负责人:ANDREW Charles LARNER
-
依托单位:
Signaling in Cells Chronically Exposed to Interferons
-
批准号:7390260
-
项目类别:
-
资助金额:$27.14万
-
财政年份:2005
-
负责人:ANDREW Charles LARNER
-
依托单位:
The Effects of Interferons on Anthrax Toxicity
-
批准号:6820434
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2004
-
负责人:ANDREW Charles LARNER
-
依托单位:
Pathways that Regulate Antigrowth Effects of Interferons
-
批准号:7059325
-
项目类别:
-
资助金额:$27.57万
-
财政年份:2004
-
负责人:ANDREW Charles LARNER
-
依托单位:
The Effects of Interferons on Anthrax Toxicity
-
批准号:6896875
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2004
-
负责人:ANDREW Charles LARNER
-
依托单位:
Pathways that Regulate Antigrowth Effects of Interferons
-
批准号:6893461
-
项目类别:
-
资助金额:$28.23万
-
财政年份:2004
-
负责人:ANDREW Charles LARNER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: